Video Exercise Mobile Application for People With Knee Osteoarthritis

May 15, 2024 updated by: Fatih Ozden

Development and Investigation of the Effectiveness of Video Exercise Mobile Application for People With Knee Osteoarthritis

The aim of our study is to realize an exercise training and follow-up system that individuals with knee OA can easily adapt.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Fethiye
      • Muğla, Fethiye, Turkey
        • Fethiye State Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosis of primary knee osteoarthritis (OA) according to the American College of Rheumatology (ACR) criteria
  • Be qualified to use the mobile application and agree to use the application

Exclusion Criteria:

  • Individuals with poor cognitive function or inadequate reading skills
  • Individuals with neurological disorders that may affect mobility skills
  • Individuals who have undergone knee joint surgery and individuals with traumatic injuries

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group

Home exercises will be delivered through a video mobile application. In this application, exercises for knee osteoarthritis will be presented according to their types (stretching, strengthening, etc.). Videos deemed appropriate by the physiotherapist will be added to the exercise prescription and sent to the patients via message. Patients will have the opportunity to remotely access their own exercise prescription with visual, auditory and written commands.

Translated with DeepL.com (free version)

Active Comparator: Control Group

Home exercises will be delivered through a video mobile application. In this application, exercises for knee osteoarthritis will be presented according to their types (stretching, strengthening, etc.). Videos deemed appropriate by the physiotherapist will be added to the exercise prescription and sent to the patients via message. Patients will have the opportunity to remotely access their own exercise prescription with visual, auditory and written commands.

Translated with DeepL.com (free version)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale (VAS)
Time Frame: Change from Baseline VAS at 8 weeks
On a 0 cm straight line or numeric scale, the patient is asked to mark the pain they feel (0: no pain, 10: excruciating pain).
Change from Baseline VAS at 8 weeks
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: Change from Baseline WOMAC at 8 weeks
WOMAC consists of 3 main headings: pain intensity, stiffness and physical function. The total score ranges from 0 (no disability) to 96 (complete disability).
Change from Baseline WOMAC at 8 weeks
Satisfaction and expectation assessment
Time Frame: Change from Baseline Satisfaction and expectation assessment at 8 weeks
On a 0 cm straight line or numeric scale, the patient will be asked to mark their pre-treatment expectation and post-treatment satisfaction level. 0 will represent the lowest expectation and satisfaction and 10 the highest expectation or satisfaction.
Change from Baseline Satisfaction and expectation assessment at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: İrem Çetinkaya, MSc, Halic University
  • Principal Investigator: Nazan Tuğay, PhD, Sanko University
  • Study Chair: Fatih Özden, PhD, Muğla Sıtkı Koçman University
  • Study Director: Baki Umut Tuğay, PhD, Muğla Sıtkı Koçman University
  • Principal Investigator: Barış Ethem Süzek, PhD, Muğla Sıtkı Koçman University
  • Principal Investigator: Zübeyir Sarı, PhD, Marmara University
  • Principal Investigator: Gülser Cinbaz, MSc, Istanbul Medeniyet University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 2, 2023

Primary Completion (Actual)

April 30, 2024

Study Completion (Actual)

May 15, 2024

Study Registration Dates

First Submitted

May 15, 2024

First Submitted That Met QC Criteria

May 15, 2024

First Posted (Actual)

May 21, 2024

Study Record Updates

Last Update Posted (Actual)

May 21, 2024

Last Update Submitted That Met QC Criteria

May 15, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Tubitak diz OA

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis, Knee

Clinical Trials on Telerehabilitation

3
Subscribe